Congress Asset Management’s Novartis NVS Stock Holding History

Congress Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-39,237	Closed	-$2.55M	–	236
2016 Q1	$2.55M	Sell	39,237 -975	-2%	-$66.3K	0.06%	158
2015 Q4	$3.1M	Buy	40,212 +5,973	+17%	+$474K	0.08%	153
2015 Q3	$2.82M	Buy	34,239 +2,724	+9%	+$242K	0.07%	151
2015 Q2	$2.78M	Buy	31,515 +1,392	+5%	+$128K	0.08%	160
2015 Q1	$2.66M	Buy	30,123 +260	+0.9%	+$23.1K	0.06%	160
2014 Q4	$2.48M	Buy	29,863 +3,317	+12%	+$275K	0.06%	163
2014 Q3	$2.24M	Buy	26,546 +2,410	+10%	+$195K	0.06%	163
2014 Q2	$1.96M	Buy	24,136 +518	+2%	+$40.7K	0.05%	175
2014 Q1	$1.8M	Buy	23,618 +1,998	+9%	+$146K	0.05%	177
2013 Q4	$1.56M	Buy	21,620 +2,536	+13%	+$176K	0.04%	176
2013 Q3	$1.31M	Buy	19,084 +2,645	+16%	+$175K	0.04%	176
2013 Q2	$1.04M	Buy	+16,439	New	+$1.07M	0.03%	172

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Congress Asset Management's NVS Position: Q2 2016 in Review

Congress Asset Management sold out of Novartis (NVS) in Q2 2016, closing a stake of 39,237 shares — an estimated $2.55M sold.

Congress Asset Management first reported a position in NVS in Q2 2013 and held it in 12 quarters. The position peaked at $3.1M in Q4 2015. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Congress Asset Management reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Congress Asset Management sold 39,237 Novartis shares in Q2 2016, an estimated $2.55M.
Congress Asset Management first reported a position in Novartis in Q2 2013 and held it in 12 quarters.
Congress Asset Management's Novartis position peaked at $3.1M in Q4 2015.
879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Congress Asset Management's 13F filing for Q2 2016, filed 4 Aug 2016.